Please use this identifier to cite or link to this item: https://doi.org/10.1128/AAC.01297-08
Title: High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia
Authors: Lee, H.-Y.
Su, L.-H.
Tsai, M.-H.
Kim, S.-W.
Chang, H.-H.
Jung, S.-I.
Park, K.-H.
Perera, J.
Carlos, C.
Ban, H.T.
Kumarasinghe, G.
So, T.
ChongthaLeong, A. 
Hsueh, P.-R.
Liu, J.-W.
Song, J.-H.
Chiu, C.-H.
Issue Date: Jun-2009
Citation: Lee, H.-Y., Su, L.-H., Tsai, M.-H., Kim, S.-W., Chang, H.-H., Jung, S.-I., Park, K.-H., Perera, J., Carlos, C., Ban, H.T., Kumarasinghe, G., So, T., ChongthaLeong, A., Hsueh, P.-R., Liu, J.-W., Song, J.-H., Chiu, C.-H. (2009-06). High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrobial Agents and Chemotherapy 53 (6) : 2696-2699. ScholarBank@NUS Repository. https://doi.org/10.1128/AAC.01297-08
Abstract: This multinational study from Asia revealed that reduced susceptibility to ciprofloxacin (MIC, 0.125 to 1 μg/ml) in nontyphoid Salmonella isolates was common in Taiwan (48.1%) and Thailand (46.2%) and in S. enterica serotype Choleraesuis (68.8%) and S. Virchow (75.0%) from all countries. Reduced susceptibility to ceftriaxone (MIC, 2 to 8 μg/ml) remained uncommon in Asia, except in Taiwan (38.0%) or in S. Typhimurium (25.0%) from all countries. Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Source Title: Antimicrobial Agents and Chemotherapy
URI: http://scholarbank.nus.edu.sg/handle/10635/133364
ISSN: 00664804
DOI: 10.1128/AAC.01297-08
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.